Cargando…
Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications
Copper (Cu) is an essential element that is involved in a variety of biochemical processes. Both deficiency and accumulation of Cu are associated with various diseases; and a high amount of accumulated Cu in cells can be fatal. The production of reactive oxygen species (ROS), oxidative stress, and c...
Autores principales: | Tarin, Mojtaba, Babaie, Maryam, Eshghi, Hossein, Matin, Maryam M., Saljooghi, Amir Sh. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589935/ https://www.ncbi.nlm.nih.gov/pubmed/37864163 http://dx.doi.org/10.1186/s12967-023-04533-5 |
Ejemplares similares
-
The Anticancer Agent Elesclomol Has Direct Effects on Mitochondrial Bioenergetic Function in Isolated Mammalian Mitochondria
por: Modica-Napolitano, Josephine S., et al.
Publicado: (2019) -
Elesclomol restores mitochondrial function in genetic models of copper deficiency
por: Soma, Shivatheja, et al.
Publicado: (2018) -
Oral Elesclomol Treatment Alleviates Copper Deficiency in Animal Models
por: Yuan, Sai, et al.
Publicado: (2022) -
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
por: Zheng, Peijie, et al.
Publicado: (2022) -
Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol
por: Blackman, Ronald K., et al.
Publicado: (2012)